People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Ken Windle B.Pharm, MPS, Non-Executive Deputy Chairman Ken has been a Director since 2001. He held a series of global commercialisation and senior management positions in Glaxo and ...
Corporate Member: Mr Ken Windle President & CEO Company Profile: Advent Pharmaceuticals Pty Ltd is an emerging pharmaceutical company, specialising in inhaled medicine drug delivery.
Kinacia's CEO Ken Windle will assume the role of chairman in the company's board of directors while Fairley will remain CEO. The major investors in the combined company are Amrad ...
Kinacia CEO Ken Windle says TGX155 may be as effective as existing drugs in stopping life-threatening clots in the arteries of the brain and heart without the ...
Ken Windle - non-executive Deputy Chairman Barrie Finnin - non-executive Director Richard Treagus - CEO and Managing Director . Auditor: Pitcher Partners
Cyril Tonkin scholarship fund Supporting graduates and students in their pursuit of excellence in pharmacy practice and research
Corporate Member: Mr Ken Windle President & CEO Company Profile: Advent Pharmaceuticals Pty Ltd is an emerging pharmaceutical company, specialising in inhaled medicine drug ...
Ken Windle B.Pharm, MPS, Non-Executive Deputy Chairman Ken has been a Director since 2001. He held a series of global commercialisation and senior management positions in ...
[PDF]
Linkedin
Advent Pharmaceuticals Pty Ltd (Pharmaceuticals industry): ceo, (2001-Present)
Glaxo Wellcome (Pharmaceuticals industry): Regional President, &n...